PMV Pharmaceuticals Financial Overview
PMV Pharmaceuticals's market cap is currently $64.92M. The company's EPS TTM is $-0.4; its P/E ratio is -0.78; PMV Pharmaceuticals is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
